Clinical Trial Update: MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial MP101 for acute Pseudomonas aeruginosa pneumonia is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• MP101

Snippet

Sponsor: MicrobiotiX Co., Ltd | Conditions: Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection | Phase 1 | Status: NOT_YET_RECRUITING